Skip to main content

Panos Macheras: a pioneering scientist in pharmaceutical science

Abstract

Professor Panos Macheras is a pioneering scientist in pharmacokinetics, pharmacodynamics and biopharmaceutics. His many important contributions to pharmaceutical science are reviewed.

This is a preview of subscription content, access via your institution.

Fig. 1
Fig. 2
Fig. 3

(Used with permission from BJCP Br J Clin Pharmacol. 2002 Jul; 54(1): 21–29)

References

  1. Valsami G, Macheras P (1995) Determination of fractal reaction dimension in dissolution studies. Eur J Pharm Sci 3:163–169

    Article  CAS  Google Scholar 

  2. Dokoumetzidis A, Macheras P (2009) Fractional kinetics in drug absorption and disposition processes. J Pharmacokinet Pharmacodyn 36:165–178

    Article  CAS  PubMed  Google Scholar 

  3. Sopasakis P, Sarimveis C, Macheras P, Dokoumetzidis A (2018) Fractional calculus in pharmacokinetics. J Pharmacokinet Pharmacodyn 45:107–125

    Article  CAS  PubMed  Google Scholar 

  4. Dokoumetzidis A, Papadopoulou V, Valsami G, Macheras P (2008) Development of a reaction-limited model of dissolution: application to official dissolution tests experiments. Int J Pharm 355:114–125

    Article  CAS  PubMed  Google Scholar 

  5. Charkoftaki G, Dokoumetzidis A, Valsami G, Macheras P (2011) Supersaturated dissolution data and their interpretation: the TPGS-carbamazepine model case. J Pharm Pharmacol 63:352–361

    Article  CAS  PubMed  Google Scholar 

  6. Rinaki E, Valsami G, Macheras P (2003) The power law can describe the “entire” release curve: a hypothesis. Int J Pharm 255:199–207

    Article  CAS  PubMed  Google Scholar 

  7. Papadopoulou V, Kosmidis K, Vlachou M, Macheras P (2006) On the use of the Weibull function for the discernment of drug release mechanisms. Int J Pharm 309:44–50

    Article  CAS  PubMed  Google Scholar 

  8. Dokoumetzidis A, Macheras P (2006) A century of dissolution research: from Noyes and Whitney to the biopharmaceutics classification system. Int J Pharm 321:1–11

    Article  CAS  PubMed  Google Scholar 

  9. Macheras P, Symillides M (1989) Toward a quantitative approach for the prediction of the fraction of dose absorbed using the absorption potential concept. Biopharm Drug Dispos 10:43–53

    Article  CAS  PubMed  Google Scholar 

  10. Daousani C, Macheras P (2016) Biopharmaceutic classification of drugs revisited. Eur J Pharm Sci 95:82–87

    Article  CAS  PubMed  Google Scholar 

  11. Macheras P, Symillides M, Reppas C (1996) An improved intercept method for the assessment of absorption rate in bioequivalence studies. Pharm Res 13:1753–1756

    Google Scholar 

  12. Macheras P, Dokoumetzidis A (2000) On the heterogeneity of drug dissolution and release. Pharm Res 17:108–112

    Article  CAS  PubMed  Google Scholar 

  13. Rinaki E, Valsami G, Macheras P (2003) Quantitative biopharmaceutics classification system (QBCS): the central role of dose/solubility ratio. Pharm Res 20:1917–1925

    Article  CAS  PubMed  Google Scholar 

  14. Macheras P, Iliadis A, Melagraki G (2018) A reaction-limited in vivo dissolution model for the study of drug absorption: towards a new paradigm for the biopharmaceutic classification of drugs. Eur J Pharm Sci 117:98–106

    Article  CAS  PubMed  Google Scholar 

  15. Kytariolos J, Dokoumetzidis A, Macheras P (2010) Power law IVIVC: an application of fractional kinetics for drug release and absorption. Eur J Pharm Sci 41:299–304

    Article  CAS  PubMed  Google Scholar 

  16. Macheras P, Karalis V, Valsami G (2013) Keeping a critical eye on the science and the regulation of oral drug absorption: a review. J Pharm Sci 102:3018–3036

    Article  CAS  PubMed  Google Scholar 

  17. Ismailos G, Reppas C, Dressman J, Macheras P (1991) Unusual solubility behaviour of cyclosporine A in aqueous media. J Pharm Pharmacol 43:287–289

    Article  CAS  PubMed  Google Scholar 

  18. Karalis V, Macheras P, Symillides M (2005) Geometric mean ratio dependent scaled bioequivalence limits with leveling-off properties. Eur J Pharm Sci 26:54–61

    Article  CAS  PubMed  Google Scholar 

  19. Kytariolos J, Karalis V, Macheras P, Symillides M (2006) Novel scaled average bioequivalence limits with leveling-off properties. Pharm Res 23:2657–2664

    Article  CAS  PubMed  Google Scholar 

  20. Macheras P, Argyrakis P, Polymilis C (1996) Fractal geometry, fractal kinetics and chaos en route to biopharmaceutical sciences. Eur J Drug Metab Pharmacokinet 21:77–86

    Article  CAS  PubMed  Google Scholar 

  21. Dokoumetzidis A, Macheras P (2011) The changing face of the rate concept in biopharmaceutical sciences: from classical to fractal and finally to fractional. Pharm Res 28:1129–1132

    Article  CAS  Google Scholar 

  22. Pispa N, Dokoumetzidis A, Demetzos Macheras P (2013) On the ubiquitous presence of fractals and fractal concepts in pharmaceutical sciences: a review. Int J Pharm 456:340–352

    Article  CAS  Google Scholar 

  23. Macheras P, Iliadis A (2016) Modeling in biopharmaceutics, pharmacokinetics and pharmacodynamics: homogeneous and heterogeneous approaches, 2nd edn. Springer, New York, p 483. https://doi.org/10.1007/978-3-319-27598-7

    Book  Google Scholar 

  24. Dokoumetzedis A, Iliadis A, Macheras P (2002) Nonlinear dynamics in clinical pharmacology: the paradigm of cortisol secretion and suppression. Br J Clin Pharmacol 54:21–29. https://doi.org/10.1046/j.1365-2125.2002.01600.x

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Laszlo Endrenyi.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Endrenyi, L., Bies, R.R. Panos Macheras: a pioneering scientist in pharmaceutical science. J Pharmacokinet Pharmacodyn 46, 105–109 (2019). https://doi.org/10.1007/s10928-019-09628-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10928-019-09628-5

Keywords

  • Pharmacokinetics
  • Pharmacodynamics
  • Biopharmaceutics
  • Bioequivalence
  • Fractal kinetics